ml 7 has been researched along with Leukemia in 1 studies
ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makishima, M | 1 |
| Honma, Y | 1 |
| Hozumi, M | 1 |
| Sampi, K | 1 |
| Hattori, M | 1 |
| Motoyoshi, K | 1 |
1 other study available for ml 7 and Leukemia
| Article | Year |
|---|---|
Induction of differentiation of human leukemia cells by inhibitors of myosin light chain kinase.
Topics: Azepines; Cell Differentiation; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Monocyt | 1991 |